Slater, R.

patient expression evi 1 leukemia group treatment blood evi 1 expression analysis study 1-evi chromosome level therapy mds 1-evi tumor protein sample marrow myeloablative fusion l-asp g-csf table transcript chemotherapy abnormality probe result number survival mrad 18sc cytogenetic sequence mds 1-evi expression bone marrow myeloma prognostic value etv 6 cycle response month leukemic cells translocation aml patients myeloablative therapy leukemic myeloablative therapy group promyelocytic leukemia karyotype 3 mg /l rad 18 mrna expression promyelocytic hlxb 9 lymphoblastic leukemia retinoic acid retinoic figure melanoma differentiation randomized myeloablative treatment chemotherapy group mouse myeloid leukemia repair yeast myeloid cell rescue hybridization transplantation uveal uveal melanoma homolog factor disease melphalan hospital